{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:48:17Z","timestamp":1750895297352,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1023\/a:1006477109230","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T02:03:28Z","timestamp":1040522608000},"page":"127-133","source":"Crossref","is-referenced-by-count":4,"title":["A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer"],"prefix":"10.1007","volume":"62","author":[{"given":"E.","family":"Esteban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonz\u00e1lez de","family":"Sande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Puertas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Palacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Vieitez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Modollel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Lacave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"271292_CR1","first-page":"669","volume-title":"Breast Diseases","author":"SF Honing","year":"1996","unstructured":"Honing SF: Treatment of metastatic disease. In: Harris JR, Hellman S, Henderson IC, et al (eds) Breast Diseases. Lippincott, Philadelphia, PA, 1996, pp. 669\u2013734"},{"key":"271292_CR2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/bjc.1993.146","volume":"67","author":"RP A'Hern","year":"1993","unstructured":"A'Hern RP, Smith IE, Ebbs SR: Chemotherapy and survival in advanced breast cancer: The inclusion doxorubicin in Cooper type regimens. Br J Cancer 67: 801\u2013805, 1993","journal-title":"Br J Cancer"},{"key":"271292_CR3","first-page":"261","volume":"70","author":"C Brambilla","year":"1986","unstructured":"Brambilla C, Rossi A, Bonfante V, et al.: Phase II study of Doxorubicin versus epirubicin in advanced breast cancer. Cancer Treat Rep 70: 261\u2013266, 1986","journal-title":"Cancer Treat Rep"},{"key":"271292_CR4","unstructured":"Hayat M, Chauvergne J, Fargeot P, et al.: Phase III chemotherapy comparing FAC versus FEC in advanced breast cancer: Preliminary results. Proc Am Assoc Clin Oncol C-460, 1984"},{"key":"271292_CR5","unstructured":"Intini C, Zingali G, de Micheli P, et al.: FEC versus FAC in Advanced Breast Cancer. Results of an Italian Cooperative study. Cancer Chemother Pharmacol suppl 1 to vol 18: A38, 149, 1986"},{"issue":"4","key":"271292_CR6","first-page":"2","volume":"16","author":"P Potier","year":"1989","unstructured":"Potier P: The synthesis of navelbine, prototype of a new series of vinblastine derivates. Semin Oncol 16(4): 2, 1989","journal-title":"Semin Oncol"},{"key":"271292_CR7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0304-3835(85)90186-7","volume":"27","author":"G Mathe","year":"1985","unstructured":"Mathe G, Reizenstein P: Phase I pharmacology study of a new vinca-alkaloid: Navelbine. Cancer Lett 27: 285\u2013293, 1985","journal-title":"Cancer Lett"},{"key":"271292_CR8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.1993.11.7.1245","volume":"11","author":"P Fumoleau","year":"1993","unstructured":"Fumoleau P, Delgado FM, Delozier T, et al.: Phase II trial of weekly intravenous vinorelbine in first line advanced breast cancer chemotherapy. J Clin Oncol 11: 1245\u20131252, 1993","journal-title":"J Clin Oncol"},{"key":"271292_CR9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/oxfordjournals.annonc.a059019","volume":"5","author":"J Garc\u00eda Conde","year":"1994","unstructured":"Garc\u00eda Conde J, Lluch A, Martin M, et al.: Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy. Ann Oncol 5: 854\u2013857, 1994","journal-title":"Ann Oncol"},{"key":"271292_CR10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/JCO.1994.12.2.336","volume":"12","author":"A Romero","year":"1994","unstructured":"Romero A, Rabinovich MG, Vallejo CT, et al.: Vinorelbine as first-line chemotherapy for metastatic breast carcinoma. J Clin Oncol 12: 336\u2013341, 1994","journal-title":"J Clin Oncol"},{"key":"271292_CR11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/bjc.1994.435","volume":"70","author":"CJ Twelves","year":"1994","unstructured":"Twelves CJ, Dobbs NA, Curnow A, et al.: A phase II multicentre UK study of vinorelbine in advanced breast cancer. Br J Cancer 70: 990\u2013993, 1994","journal-title":"Br J Cancer"},{"key":"271292_CR12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00000421-199510000-00006","volume":"18","author":"S Bruno","year":"1995","unstructured":"Bruno S, Puerto VL, Mickiewicz E, et al.: Phase II trial of weekly IV vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience. Am J Clin Oncol 18: 392\u2013396, 1995","journal-title":"Am J Clin Oncol"},{"key":"271292_CR13","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1200\/JCO.1995.13.11.2722","volume":"13","author":"BL Weber","year":"1995","unstructured":"Weber BL, Vogel C, Jones S, et al.: Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. J Clin Oncol 13: 2722\u20132730, 1995","journal-title":"J Clin Oncol"},{"issue":"4","key":"271292_CR14","first-page":"117","volume":"13","author":"I Palacio","year":"1996","unstructured":"Palacio I, De las Pe\u00f1as R, Esteban E, et al.: Vinorelbina como agente \u00fanico en el tratamiento del c\u00e1ncer de mama metast\u00e1tico en segunda l\u00ednea. Estudio de Fase II del Grupo Oncol\u00f3gico del Noroeste (GON). Neoplasia 13(4): 117\u2013120, 1996","journal-title":"Neoplasia"},{"key":"271292_CR15","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1200\/JCO.1995.13.10.2567","volume":"13","author":"S Jones","year":"1995","unstructured":"Jones S, Winer E, Vogel C, et al.: Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer. J Clin Oncol 13: 2567\u20132574, 1995","journal-title":"J Clin Oncol"},{"key":"271292_CR16","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1200\/JCO.1994.12.9.1764","volume":"12","author":"M Spielmann","year":"1994","unstructured":"Spielmann M, Dorval T, Turpin F, et al.: Phase II trial of vinorelbine\/doxorubicin as first line therapy of advanced breast cancer. J Clin Oncol 12: 1764\u20131770, 1994","journal-title":"J Clin Oncol"},{"key":"271292_CR17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1006387801960","volume":"58","author":"E Esteban","year":"1999","unstructured":"Esteban E, Lacave AJ, Fern\u00e1ndez JL, et al.: Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer. Breast Cancer Res Treat 58: 141\u2013150, 1999","journal-title":"Breast Cancer Res Treat"},{"key":"271292_CR18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM197902083000603","volume":"300","author":"J Alexander","year":"1979","unstructured":"Alexander J, Daimak N, Berber HJ, et al.: Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med 300: 278\u2013283, 1979","journal-title":"N Engl J Med"},{"key":"271292_CR19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, et al.: Reporting results of cancer treatment. Cancer 47: 207\u2013214, 1981","journal-title":"Cancer"},{"key":"271292_CR20","first-page":"89","volume":"13","author":"JL Hayward","year":"1977","unstructured":"Hayward JL, Carbone PP, Heuson JC, et al.: Assessment of response to therapy in advanced breast cancer. Eur J Cancer Clin Oncol 13: 89\u201394, 1977","journal-title":"Eur J Cancer Clin Oncol"},{"key":"271292_CR21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457\u2013481, 1958","journal-title":"J Am Stat Assoc"},{"key":"271292_CR22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.1984.2.11.1281","volume":"2","author":"W Hryniuk","year":"1984","unstructured":"Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2: 1281, 1984","journal-title":"J Clin Oncol"},{"key":"271292_CR23","unstructured":"Chadjaa M, Izzo J, May-Levin F, et al.: Preliminary data on 4 \u00e9piadriamycin\u2013vinorelbin: a new active combination in advanced breast cancer. Proc. of IV Internat Congress on Anticancer Chemotherapy (SOMPS): 148 (abst P43), 1993"},{"key":"271292_CR24","first-page":"647","volume":"16","author":"C Nistico","year":"1997","unstructured":"Nistico C, Garufi C, Pace R, et al.: Weekly epirubicin and vinorelbine plus G-CSF in metastatic breast cancer (MBC): high activity with a 75% survival rate at two years Proc Am Soc Clin Oncol: 16: 647, 1997.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"271292_CR25","first-page":"437","volume":"18","author":"P Vici","year":"1999","unstructured":"Vici P, Amodio A, Di Lauro L, et al.: A multicentric phase II trial of vinorelbine and epirubicin as first line chemotherpary in metastatic breast cancer. Preliminary data. Proc Am Soc Clin Oncol: 18: 437, 1999.","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"1","key":"271292_CR26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/bjc.1997.7","volume":"75","author":"J Carmichael","year":"1997","unstructured":"Carmichael J, Hegg R, Firat D, et al.: Navelbine and fractionated dose doxorubicin improves 1st line treatment of advanced breast cancer. An overview of 3 phase II trials. Br J Cancer 75(1): 85: 40, 1997","journal-title":"Br J Cancer"},{"key":"271292_CR27","first-page":"433","volume":"18","author":"AC Braud","year":"1999","unstructured":"Braud AC, Jauffret E, Thirion P, et al.: Phase II study of vinorelbine, epirubicin and cyclophosphamide (NEC) as first line chemotherapy in patients with metastatic breast cancer: Preliminary results. Proc Am Soc Clin Oncol 18: 433, 1999","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"5","key":"271292_CR28","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1091::AID-CNCR12>3.0.CO;2-A","volume":"85","author":"C Blajman","year":"1999","unstructured":"Blajman C, Balbiani L, Bloc J, et al.: A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in treatment of advanced breast carcinoma: Cancer 85(5): 1091\u20131097, 1999","journal-title":"Cancer"},{"key":"271292_CR29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<104::AID-CNCR15>3.0.CO;2-R","volume":"85","author":"ZU Rahman","year":"1999","unstructured":"Rahman ZU, Frye DK, Smith TL, et al.: Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy. Cancer 85: 104\u2013111, 1999","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006477109230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006477109230\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1006477109230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006477109230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:27:52Z","timestamp":1750480072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006477109230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["271292"],"URL":"https:\/\/doi.org\/10.1023\/a:1006477109230","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}